To access this element change to forms mode OFF
Grant Award View - GA205190
Development of a novel glucose lowering medication targeting mTORC1 in...
GA ID:
GA205190
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
13-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 1-Jan-2025
Value (AUD):
$649,347.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Development of a novel glucose lowering medication targeting mTORC1 in osteoblasts.
Purpose:
New medications to lower blood sugar levels are desperately needed to help treat the many millions of people at risk of developing chronic diseases associated with obesity and Type 2 diabetes (T2DM). Our group has identified a new drug target in bone forming cells. This target becomes over-activated in obesity and decreases the ability of insulin to stimulate sugar uptake. In this proposal, we will develop a novel inhibitor and test the inhibitor in a model system of diet-induced T2DM.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011953
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Adelaide
Recipient ABN:
61 249 878 937
Grant Recipient Location
Suburb:
Adelaide
Town/City:
Adelaide
Postcode:
5000
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, SA
Postcode:
Multiple
Country:
AUSTRALIA